Related Experiment Video

Updated: Aug 16, 2026

Gap Junctional Intercellular Communication: A Functional Biomarker to Assess Adverse Effects of Toxicants and Toxins, and Health Benefits of Natural Products
05:27

Gap Junctional Intercellular Communication: A Functional Biomarker to Assess Adverse Effects of Toxicants and Toxins, and Health Benefits of Natural Products

Published on: December 25, 2016

Effect of 7,12-dimethylbenz(a)anthracene on onco/suppressor gene action in vivo: a short-term experiment

I Ember1, I Kiss, Z Pusztai

  • 1Department of Preventive Medicine, University Medical School of Pecs, Hungary.

Anticancer Research
|May 6, 1998
PubMed

Insights

Dimethylbenz[a]anthracene (DMBA), a carcinogen, affects gene expression. DMBA increased oncogene expression in rat spleens but not livers, suggesting potential for gene expression screening in humans.

Area of Science:

  • Toxicology
  • Molecular Biology
  • Carcinogenesis

Background:

  • Dimethylbenz[a]anthracene (DMBA) is a known carcinogen that initiates tumors by causing mutations in oncogenes and tumor suppressor genes.
  • Altered gene expression, particularly of oncogenes, is a hallmark of carcinogenic processes.
  • Investigating gene expression changes provides insights into the mechanisms of chemical carcinogenesis.

Purpose of the Study:

  • To investigate the effect of a single dose of DMBA on the expression of specific oncogenes (c-myc, c-Ha-ras, p53) in the liver and spleen of Long-Evans rats.
  • To determine if DMBA exposure leads to significant transcriptional changes in these key genes.
  • To evaluate the potential of gene expression analysis as a screening method for environmental carcinogen exposure.

Main Methods:

  • Long-Evans rats were administered a single dose of DMBA or a control solvent (corn oil).
  • Gene expression levels of c-myc, c-Ha-ras, and p53 were analyzed in liver and spleen tissues 24 hours post-treatment.
  • Transcriptional levels were compared between DMBA-exposed and control groups.

Main Results:

  • No significant changes in the transcriptional levels of the investigated oncogenes were observed in the liver.
  • In the spleen, DMBA treatment resulted in a 2-fold overexpression of Ha-ras and a 3-fold overexpression of c-myc compared to controls.
  • p53 expression levels were not detailed in the provided abstract but were part of the investigation.

Conclusions:

  • DMBA exposure differentially affects oncogene expression in rat spleen and liver.
  • The spleen appears more sensitive to DMBA-induced oncogene transcriptional changes than the liver.
  • These findings support the utility of gene expression profiling as a potential screening tool for human exposure to environmental carcinogens like DMBA.

More Related Videos

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling09:33

Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling

Published on: March 20, 2018

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)04:12

Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)

Published on: December 19, 2019

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...